Coronavirus: Moderna to begin testing vaccine in children

Pharmaceutical company Moderna said Wednesday it will begin testing its vaccine in children.

The study will include 3,000 children aged 12 to 17 years old, The New York Times reported. Half will be given two shots of a vaccine four weeks apart and the others a placebo of salt water.

However, the trial is not yet accepting volunteers, Colleen Hussey, a Moderna spokeswoman, told the Times. A link to active test centers could become active Monday.

>> Coronavirus: Moderna says new results show vaccine 94% effective; company seeking emergency OK today

On Monday, Moderna said its vaccine is 94% effective in clinical trials. However vaccines can not be given to children until they are tested in them. Moderna’s vaccine still has not been tested in children and pregnant women.

More coronavirus pandemic coverage:

>> Coronavirus: CDC acknowledges airborne transmission of COVID-19

>> Is it COVID-19, flu, cold or allergies? What is causing you to feel sick this year

>> Coronavirus: CDC updates guidance for COVID-19 testing

>> Dangerous hand sanitizer list up to more than 150 products, FDA announces

>> Wash your masks: How to clean a cloth face covering

>> Fact check: Will masks lower the oxygen level, raise the carbon dioxide in your blood?

>> How to not let coronavirus pandemic fatigue set in, battle back if it does

Cox Media Group